Atlas Trials

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

Clinical trial NCT07034859 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07034859
Sponsor
National Taiwan University Hospital
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Pituitary AdenomaMRIRCT
Start date
2024-05-20
Primary completion
2028-10-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.